Paper4728343
Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC).
Sofia RD and 3 others. J Pharmacol Exp Ther, 1973. Cited by 106 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC). Papers, record 4728343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4728343
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Analgesics | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Cannabis | Major topic |
| Abdomen | |
| Acetates | |
| Adjuvants, Immunologic | |
| Adrenal Glands | |
| Adrenalectomy | |
| Animals | |
| Arthritis | |
| Aspirin | |
| Carrageenan | |
| Dronabinol | |
| Edema | |
| Hydrocortisone | |
| Hypophysectomy | |
| Male | |
| Pituitary Gland | |
| Pressure | |
| Rats | |
| Rats, Inbred Strains | |
| Tail | |
| Yeast, Dried |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,870,742 | Cannabis Derivatives as Ingredients of Functional Foods to Combat the COVID-19 Pandemic. | Foods | 2025 | https://conductscience.org/library/papers/40870742 | PubMed |
| 38,607,548 | Cannabinoids for Acute Pain Management: Approaches and Rationale. | Curr Pain Headache Rep | 2024 | https://conductscience.org/library/papers/38607548 | PubMed |
| 37,414,560 | Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation. | J Neurosci | 2023 | https://conductscience.org/library/papers/37414560 | PubMed |
| 37,214,578 | Medicinal cannabis products for the treatment of acute pain. | World J Clin Cases | 2023 | https://conductscience.org/library/papers/37214578 | PubMed |
| 37,017,445 | Endocannabinoid System: Chemical Characteristics and Biological Activity. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37017445 | PubMed |
| 36,552,866 | Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases. | Cells | 2022 | https://conductscience.org/library/papers/36552866 | PubMed |
| 35,625,855 | Impact of Δ9-Tetrahydrocannabinol on Rheumatoid Arthritis Synovial Fibroblasts Alone and in Co-Culture with Peripheral Blood Mononuclear Cells. | Biomedicines | 2022 | https://conductscience.org/library/papers/35625855 | PubMed |
| 34,202,812 | Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies. | Molecules | 2021 | https://conductscience.org/library/papers/34202812 | PubMed |
| 30,976,189 | The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPRER and beyond. | Saudi Pharm J | 2019 | https://conductscience.org/library/papers/30976189 | PubMed |
| 30,225,659 | Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain. | Psychopharmacology (Berl) | 2018 | https://conductscience.org/library/papers/30225659 | PubMed |
| 28,857,069 | The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. | Neuropsychopharmacology | 2018 | https://conductscience.org/library/papers/28857069 | PubMed |
| 28,188,220 | Cannabinoids Activate Monoaminergic Signaling to Modulate Key C. elegans Behaviors. | J Neurosci | 2017 | https://conductscience.org/library/papers/28188220 | PubMed |
| 21,740,924 | Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. | Pharmacol Biochem Behav | 2011 | https://conductscience.org/library/papers/21740924 | PubMed |
| 20,375,198 | Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase. | J Pharmacol Exp Ther | 2010 | https://conductscience.org/library/papers/20375198 | PubMed |
| 18,615,148 | Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing. | Curr Neuropharmacol | 2006 | https://conductscience.org/library/papers/18615148 | PubMed |
| 16,968,947 | The endocannabinoid system as an emerging target of pharmacotherapy. | Pharmacol Rev | 2006 | https://conductscience.org/library/papers/16968947 | PubMed |
| 12,648,025 | Pharmacokinetics and pharmacodynamics of cannabinoids. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/12648025 | PubMed |
| 11,786,493 | Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. | Br J Pharmacol | 2002 | https://conductscience.org/library/papers/11786493 | PubMed |
| 10,353,438 | Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action. | Psychopharmacology (Berl) | 1999 | https://conductscience.org/library/papers/10353438 | PubMed |
| 8,815,936 | Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects. | J Neurosci | 1996 | https://conductscience.org/library/papers/8815936 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4728343
GET https://conductscience.org/api/papers/v1/4728343/cited_by?page=2